Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter T Donaldson

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Seminars in Liver Disease|November 26, 2002
Genetics in autoimmune hepatitisPeter T Donaldson
Hepatology (Baltimore, Md.)|May 4, 2011
Electrostatic modifications of the human leukocyte antigen DR P9 peptide-binding pocket in primary sclerosing cholangitis: back to the future with human leukocyte antigen DRβPeter T Donaldson
Journal of Hepatology|August 4, 2004
Genetics of autoimmune and viral liver diseases; understanding the issuesPeter T Donaldson
Autoimmunity|May 27, 2003
Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitisPeter T Donaldson, Suzanne Norris
The American Journal of Gastroenterology|August 23, 2002
Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitisAlbert J Czaja, Peter T Donaldson
Clinics in Liver Disease|October 5, 2002
Genetic effects on susceptibility, clinical expression, and treatment outcome of type 1 autoimmune hepatitisPeter T Donaldson, Albert J Czaja
Clinics in Liver Disease|November 5, 2003
Genetic factors in the pathogenesis of primary biliary cirrhosisDavid E J Jones, Peter T Donaldson
Digestive Diseases and Sciences|October 25, 2002
Genetic bases of autoimmune hepatitisAlbert J Czaja, Derek G Doherty, Peter T Donaldson
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|June 27, 2002
Polymorphisms in immunoregulatory genes: towards individualized immunosuppressive therapy?Ann K Daly, Christopher P Day, Peter T Donaldson
The American Journal of Gastroenterology|February 28, 2002
Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitisAlbert J Czaja, Peter T Donaldson, Ansgar W Lohse
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Seminars in Liver Disease|November 26, 2002
Genetics in autoimmune hepatitisPeter T Donaldson
Hepatology (Baltimore, Md.)|May 4, 2011
Electrostatic modifications of the human leukocyte antigen DR P9 peptide-binding pocket in primary sclerosing cholangitis: back to the future with human leukocyte antigen DRβPeter T Donaldson
Journal of Hepatology|August 4, 2004
Genetics of autoimmune and viral liver diseases; understanding the issuesPeter T Donaldson
Autoimmunity|May 27, 2003
Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitisPeter T Donaldson, Suzanne Norris
The American Journal of Gastroenterology|August 23, 2002
Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitisAlbert J Czaja, Peter T Donaldson
Clinics in Liver Disease|October 5, 2002
Genetic effects on susceptibility, clinical expression, and treatment outcome of type 1 autoimmune hepatitisPeter T Donaldson, Albert J Czaja
Clinics in Liver Disease|November 5, 2003
Genetic factors in the pathogenesis of primary biliary cirrhosisDavid E J Jones, Peter T Donaldson
Digestive Diseases and Sciences|October 25, 2002
Genetic bases of autoimmune hepatitisAlbert J Czaja, Derek G Doherty, Peter T Donaldson
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|June 27, 2002
Polymorphisms in immunoregulatory genes: towards individualized immunosuppressive therapy?Ann K Daly, Christopher P Day, Peter T Donaldson
The American Journal of Gastroenterology|February 28, 2002
Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitisAlbert J Czaja, Peter T Donaldson, Ansgar W Lohse
Pageof 3